Bone metabolism during long-term treatment with imatinib

MeSH terms

• Adult
• Antineoplastic Agents / pharmacology*
• Antineoplastic Agents / therapeutic use
• Benzamides / pharmacology*
• Benzamides / therapeutic use
• Biomarkers
• Bone Density
• Bone and Bones / drug effects*
• Bone and Bones / metabolism*
• Female
• Follow-Up Studies
• Humans
• Imatinib Mesylate
• Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy
• Leukemia, Myelogenous, Chronic, BCR-ABL Positive / metabolism
• Male
• Middle Aged
• Piperazines / pharmacology*
• Piperazines / therapeutic use
• Protein Kinase Inhibitors / pharmacology*
• Protein Kinase Inhibitors / therapeutic use
• Pyrimidines / pharmacology*
• Pyrimidines / therapeutic use